Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04000529 |
Title | Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | ESP | DEU | BEL | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Novartis Investigative Site | Westmead | New South Wales | 2145 | Australia | Details | |
Novartis Investigative Site | Bruxelles | 1200 | Belgium | Details | ||
Novartis Investigative Site | Chengdu | Sichuan | 610041 | China | Details | |
Novartis Investigative Site | Koeln | 50937 | Germany | Details | ||
Novartis Investigative Site | Hong Kong | Hong Kong | Details | |||
Novartis Investigative Site | Chuo ku | Tokyo | 104 0045 | Japan | Details | |
Novartis Investigative Site | Singapore | 119228 | Singapore | Details | ||
Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
Novartis Investigative Site | Valencia | Comunidad Valenciana | 46010 | Spain | Details |